Results 151 to 160 of about 1,036 (190)

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. [PDF]

Antioxidants (Basel)
Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E, Oksenych V, Kamyshnyi O.   +7 more
europepmc   +1 more source

Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complications. [PDF]

Ren Fail
Lei Y, Xiong G, Lei D, Wu H, Peng X, Chen L, Fang Q, Wu Y, Wu Y, Li X, Li Y.   +10 more
europepmc   +1 more source

The Use of Nutritional Interventions to Enhance Genomic Stability in Mice and Delay Aging. [PDF]

Nutrients
van Galen I, Hoeijmakers JHJ, Vermeij WP.   +2 more
europepmc   +1 more source

Dysfunction of the carnitine cycle in tumor progression. [PDF]

Heliyon
Wang X, Yang C, Huang C, Wang W.
europepmc   +1 more source

Inhibition of systemic mammalian metabolism by carnitine mimics from the gut microbiota

Thümmler K, Basak S, Hulme H, Dritsa C, Foreman R, Naseer H, Salah E, Tumber A, Worboys S, Douce G, Haggarty J, Williams R, Taylor V, Ormsby MJ, Whitfield PD, McCullagh JSO, Salt IP, Burchmore R, Goodwin RJA, Schofield CJ, Wall DM.   +20 more
europepmc   +1 more source

Hyperpolarized-MRI in Hypertrophic Cardiomyopathy: A Narrative Review. [PDF]

Clin Med Insights Cardiol
Malik A, Kundur SP, Sivalokanathan S.
europepmc   +1 more source

Trimethylamine-<i>N</i>-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body. [PDF]

Ann Med
Heinrich-Sanchez Y, Vital M.
europepmc   +1 more source

L-Carnitine and Mildronate Demonstrate Divergent Protective Effects on Mitochondrial DNA Quality Control and Inflammation Following Traumatic Brain Injury. [PDF]

Int J Mol Sci
Gureev AP, Nesterova VV, Babenkova PI, Ivanov ME, Plotnikov EY, Silachev DN.   +5 more
europepmc   +1 more source

Characteristics of the Fatty Acid Composition in Elderly Patients with Occupational Pathology from Organophosphate Exposure. [PDF]

Diagnostics (Basel)
Goncharov NV, Savelieva EI, Koneva TA, Gustyleva LK, Vasilieva IA, Belyakov MV, Voitenko NG, Belinskaia DA, Korf EA, Jenkins RO.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Urinary excretion studies of meldonium after multidose parenteral application

Journal of Pharmaceutical and Biomedical Analysis, 2018
Meldonium is a drug exhibiting cardioprotective and anti-ischemic effects. Due to its potential performance-enhancing benefit in sports, meldonium was added to the World Anti-Doping Agency list of prohibited substances in 2016. Since then, a high number of adverse analytical findings reported on meldonium has questioned meldonium`s detection time in ...
Guro Forsdahl, Biljana Jančić-Stojanović, Nenad Dikić   +2 more
exaly   +5 more sources